Automation index

How much of a BIM modeller’s job can AI already do?

A model and a clash come earlier. The site being able to build from that model do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

28%

AI can already do 28% of this job.

#109 / 623

BIM modeller

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Model, families and clash detection. Estimate No public source provides a precise figure. This is our estimate.	18%	52%	+9.4
IFC, BEP and trade coordination. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Site, the one who will not open the model, and the meeting. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Quantities, parameters and the 4D nobody uses. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The last-minute change and not breaking the federated model. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
That it can be built, and not over-modelling. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		28%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 623

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low